EU delays new drug law proposal

A busy few weeks means the Commission is unable to present its proposal for overhauled pharma legislation, which was anticipated on March 29.
Photo: Heiko Becker
Photo: Heiko Becker
by albert rønning-andersson, translated by daniel pedersen

Pharmaceutical companies operating in Europe eagerly awaiting the chance to dive into an extensive revision to the EU pharma legislation must arm themselves with patience. The EU Commission has delayed the publication of the rule revamp in the area, reports Endpoints News. 

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading